Imunon (IMNN) Earnings Analysis

Imunon (IMNN) has no confirmed upcoming earnings date. Last quarter (2026-03-31) it beat with EPS -1.29 USD vs -1.43 USD est (+9.8%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -0.27.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IMNN next report earnings?

No confirmed upcoming earnings date is currently scheduled for IMNN. This page updates as the calendar is published.

IMNN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-31-1.29 USD-1.43 USD+9.8%Beat
2025-11-13-1.16 USD-1.73 USD+32.9%Beat
2025-05-12-3.65 USD-4.56 USD+20%Beat
2025-02-27-0.23 USD-0.36 USD+36.1%Beat
2024-11-07-0.34 USD-0.37 USD+8.1%Beat
2024-08-14-0.51 USD-0.55 USD+7.3%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

IMNN valuation and analyst view

Trailing P/E-0.27
Trailing EPS-2.91142 USD
Price / book2.38
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (3 buy / 1 hold / 0 sell)
Avg price target10 USD

Related research pages

Frequently asked questions

When is Imunon (IMNN)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for IMNN. This page updates as the calendar is published.

Did IMNN beat earnings last quarter?

In its 2026-03-31 report, IMNN posted EPS of -1.29 USD versus a -1.43 USD estimate — a beat of 9.8%.

What is IMNN's earnings track record?

Over the last 6 reported quarters with consensus data, IMNN beat estimates 6 times (100%).

What is IMNN's current P/E ratio and EPS?

IMNN trades at a trailing P/E of -0.27 on trailing EPS of -2.911419168820839 USD.

What do analysts rate IMNN?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 10 USD.